Evidence map

ArticleEndocrine-related cancer2018

Differential efatutazone's impact on mammary neoplasia dependent upon Brca1 dose.

Sahar J Alothman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2018
2019
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30400020